Medicine price: quote on request. Your total cost is quoted in writing per case.
We give you a written timeline estimate for your case before you commit.Get my quote

Is Lynozyfic available in Kuwait? How families get Lynozyfic (linvoseltamab-gcpt)

Creator: Reserve Meds
Published: 2026-10-13

A plain answer for families in Kuwait, checked against FDA, manufacturer and regulator sources.

Reviewed by the Reserve Meds clinical operations team on 13 October 2026.

Is Lynozyfic available in Kuwait?

Lynozyfic (linvoseltamab-gcpt) is an FDA-approved BCMA x CD3 bispecific antibody for relapsed or refractory multiple myeloma after at least four prior lines. As of 13 October 2026, we found no public record that Lynozyfic is registered by MOH in Kuwait. The legal route is a named-patient request: the treating hospital, on your specialist's request, asks the Kuwait Ministry of Health (MOH) for permission to import Lynozyfic for one patient, using the US FDA approval as the reference. Once approved, Reserve Meds arranges supply through a US-licensed pharmaceutical wholesale partner to the hospital pharmacy. We do not prescribe. We give you a written timeline estimate for your case before you commit.

Registration in Kuwait: not found in public sources as of 13 October 2026. Your hospital confirms before filing.
Legal route: Named-patient import request to MOH, filed by the treating hospital.
Who applies: your treating hospital in Kuwait, through the Ministry of Health, on the request of your treating specialist.
We give you a written timeline estimate for your case before you commit.
Price: Every case gets a written custom quote before you commit.

What Lynozyfic is

Lynozyfic (linvoseltamab-gcpt) is made by Regeneron. The US FDA approved it on 2 July 2025 for adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 monoclonal antibody. It is given as an intravenous (IV) infusion, with step-up doses and a 24-hour hospital stay after the first two step-up doses, then weekly and later every two or four weeks.

The FDA gave accelerated approval. Continued approval may depend on a confirmatory trial. It has a boxed warning for cytokine release syndrome (CRS) and neurologic toxicity. In the US it is available only through a restricted safety program (REMS).

It is also approved in the European Union for adults after at least three prior therapies.

The legal route in Kuwait

In Kuwait, the Ministry of Health (MOH) controls which medicines are registered and imported.

Under Ministerial Resolution No. 100 of 2023, a non-registered medicine can be brought in when it is used to diagnose, treat or prevent disease, it is already registered with an overseas regulator such as the US FDA, and no alternative is available in Kuwait. The request is made through MOH and follows the rules of its registration and control department. Your treating hospital starts this process.

MOH has worked with manufacturers to bring in new specialty therapies before. For example, MOH, AAW and Roche announced the registration and introduction of the Duchenne gene therapy Elevidys in Kuwait in June 2024.

Ask your hospital pharmacy to confirm the current status with the Ministry of Health's drug registration and control department before anything is filed.

Who does what

Your treating specialist decides whether Lynozyfic is right for the patient and writes the letter and prescription.
The hospital files the request and is responsible for giving the medicine safely.
The Kuwait Ministry of Health (MOH) decides whether to approve an import of an unregistered medicine.
Regeneron makes Lynozyfic and decides where it can be supplied.
Reserve Meds coordinates the paperwork, the US supply through our wholesale partner, shipping and updates to your family. We do not give medical advice.

Documents the hospital will usually need

A letter from the treating specialist: diagnosis, past treatments, and why Lynozyfic is needed
A prescription with the dose and how long treatment should last
Supporting reports, such as pathology, genetic or laboratory results
The hospital's request form and its signed declaration of responsibility
Written consent from the patient or a legal guardian
Proof of the US FDA approval and the US prescribing information (we can supply these)

Timeline, step by step

Doctor's letter. Your specialist writes the clinical letter and prescription.
Hospital request. The hospital pharmacy files the named-patient request with MOH.
Regulator decision. MOH reviews the request and issues an approval or asks for more information.
US sourcing. Our US-licensed wholesale partner supplies the medicine, and it is shipped with the right temperature controls.
Hospital receipt. The medicine is received at the hospital pharmacy, which gives it to the patient.

The overall time is our planning estimate, not a promise. The regulator and the manufacturer set their own timelines.

What Lynozyfic costs

Your total cost depends on the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

How Reserve Meds helps

Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We help your doctor and hospital prepare the file, arrange US supply and shipping once approval is in place, and keep your family updated. We coordinate access to FDA-approved medicines only. We do not prescribe, and we do not decide what the regulator approves.

Ask about Lynozyfic in Kuwait

Tell us the medicine and your country. We reply within one business day. On WhatsApp we usually reply the same day.

Frequently asked questions

Is Lynozyfic approved in Kuwait?

As of 13 October 2026, we found no public record that Lynozyfic is registered by MOH in Kuwait. It is also approved in the European Union for adults after at least three prior therapies. Ask your hospital pharmacy to confirm the current status with the Ministry of Health's drug registration and control department before anything is filed.

Who applies for permission to use Lynozyfic in Kuwait?

The treating hospital applies to the Kuwait Ministry of Health (MOH), on the written request of your specialist. Families do not apply on their own, and Reserve Meds does not apply for you.

How long does it take to get Lynozyfic in Kuwait?

We give you a written timeline estimate for your case before you commit. The regulator's review time and shipping can change this.

How much does Lynozyfic cost?

Your total cost, including shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.

Can Reserve Meds send Lynozyfic straight to our home?

No. Lynozyfic goes to the hospital pharmacy named in the regulator's approval, which then gives it to the patient. Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We are not a pharmacy.

Sources

Checked on 13 October 2026. Regulator rules change. Your hospital pharmacy confirms the current procedure before filing.